This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2009 Sep;36(5):E232-40.

doi: 10.1188/09.ONF.E232-E240.

Head's up on the treatment of malignant glioma patients

Terri S Armstrong¹

Affiliations

PMID: 19726382
DOI: 10.1188/09.ONF.E232-E240

Review

Head's up on the treatment of malignant glioma patients

Terri S Armstrong. Oncol Nurs Forum. 2009 Sep.

. 2009 Sep;36(5):E232-40.

doi: 10.1188/09.ONF.E232-E240.

Author

Terri S Armstrong¹

Affiliation

¹ Department of Integrative Nursing Care, School of Nursing, University of Texas Health Science Center, Houston, TX, USA. tsarmstr@mdanderson.org

PMID: 19726382
DOI: 10.1188/09.ONF.E232-E240

No abstract available

PubMed Disclaimer

Similar articles

[Latest treatment strategies for malignant gliomas].
Shono T, Mizoguchi M, Sasaki T. Shono T, et al. Fukuoka Igaku Zasshi. 2007 Sep;98(9):333-6. Fukuoka Igaku Zasshi. 2007. PMID: 17974076 Review. Japanese. No abstract available.
Malignant gliomas in adults.
Wen PY, Kesari S. Wen PY, et al. N Engl J Med. 2008 Jul 31;359(5):492-507. doi: 10.1056/NEJMra0708126. N Engl J Med. 2008. PMID: 18669428 Review. No abstract available.
[The treatment of adult glioma is multiphasic].
Mäenpää HO. Mäenpää HO. Duodecim. 2010;126(14):1669-75. Duodecim. 2010. PMID: 20804085 Review. Finnish.
Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Stupp R, Roila F; ESMO Guidelines Working Group. Stupp R, et al. Ann Oncol. 2008 May;19 Suppl 2:ii83-5. doi: 10.1093/annonc/mdn099. Ann Oncol. 2008. PMID: 18456781 No abstract available.
Emerging therapies for malignant glioma.
Lukas RV, Boire A, Nicholas MK. Lukas RV, et al. Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S29-36. doi: 10.1586/14737140.7.12s.S29. Expert Rev Anticancer Ther. 2007. PMID: 18076315 Review.

See all similar articles

Cited by

Measuring clinical benefit: use of patient-reported outcomes (PRO) in primary brain tumor clinical trials.
Armstrong TS. Armstrong TS. Curr Oncol Rep. 2013 Feb;15(1):27-32. doi: 10.1007/s11912-012-0276-2. Curr Oncol Rep. 2013. PMID: 23054936
Sleep loss and its effects on health of family caregivers of individuals with primary malignant brain tumors.
Pawl JD, Lee SY, Clark PC, Sherwood PR. Pawl JD, et al. Res Nurs Health. 2013 Aug;36(4):386-99. doi: 10.1002/nur.21545. Epub 2013 Apr 30. Res Nurs Health. 2013. PMID: 23633116 Free PMC article.
Perspectives of Glioblastoma Patients on Death and Dying: A Qualitative Study.
Raju B, Krishna Reddy N. Raju B, et al. Indian J Palliat Care. 2018 Jul-Sep;24(3):320-324. doi: 10.4103/IJPC.IJPC_171_17. Indian J Palliat Care. 2018. PMID: 30111946 Free PMC article.
Growth inhibitory effects of the Diruthenium-Ibuprofen compound, [Ru2Cl(Ibp) 4], in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo.
Benadiba M, de M Costa I, Santos RL, Serachi FO, de Oliveira Silva D, Colquhoun A. Benadiba M, et al. J Biol Inorg Chem. 2014 Aug;19(6):1025-35. doi: 10.1007/s00775-014-1143-4. Epub 2014 May 14. J Biol Inorg Chem. 2014. PMID: 24824561

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Oncology Nursing Society
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information